White blood cell and lymphocyte counts before and after treatment, and NCI toxicity grading
Patient no. . | Pretreatment WBC count, 103/μL . | Pretreatment absolute lymphocyte count, 103/μL NCI grade* . | Posttreatment WBC count, 103/μL NCI grade* . | Posttreatment lymphocyte count, 103/μL (NCI grade) . |
|---|---|---|---|---|
| 1 | 4.3 | 2107 | 1.4 (3) | 574 (3) |
| 2 | 7.3 | 1022 (2) | 2.2 (2) | 1846 (1) |
| 3 | 6.6 | 330 (4) | 2.9 (2) | 456 (4) |
| 4 | 4.7 | 517 (3) | 5.3 | 890 (3) |
| 5 | 10.0 | 900 (3) | 7.3 | 511 (3) |
| 6 | 7.9 | 1817 (1) | 5.3 | 1377 (2) |
| 7 | 15.0 | 4350 | 11.0 | 4290 |
| 8 | 8.7 | 1479 (2) | 4.5 | 1164 (2) |
| 9 | 4.0 | 800 (3) | 2.8 (2) | 742 (3) |
| 10 | 7.3 | 1241 (2) | 7.3 | 1660 (1) |
| 11 | 6.4 | 1920 | 3.6 (1) | 520 (3) |
| 12 | 7.5 | 1125 (2) | 5.1 | 124 (4) |
| 13 | 6.1 | 1098 (2) | 5.8 | 928 (3) |
| 14 | 12.3 | 5166 | 7.3 | 3139 |
Patient no. . | Pretreatment WBC count, 103/μL . | Pretreatment absolute lymphocyte count, 103/μL NCI grade* . | Posttreatment WBC count, 103/μL NCI grade* . | Posttreatment lymphocyte count, 103/μL (NCI grade) . |
|---|---|---|---|---|
| 1 | 4.3 | 2107 | 1.4 (3) | 574 (3) |
| 2 | 7.3 | 1022 (2) | 2.2 (2) | 1846 (1) |
| 3 | 6.6 | 330 (4) | 2.9 (2) | 456 (4) |
| 4 | 4.7 | 517 (3) | 5.3 | 890 (3) |
| 5 | 10.0 | 900 (3) | 7.3 | 511 (3) |
| 6 | 7.9 | 1817 (1) | 5.3 | 1377 (2) |
| 7 | 15.0 | 4350 | 11.0 | 4290 |
| 8 | 8.7 | 1479 (2) | 4.5 | 1164 (2) |
| 9 | 4.0 | 800 (3) | 2.8 (2) | 742 (3) |
| 10 | 7.3 | 1241 (2) | 7.3 | 1660 (1) |
| 11 | 6.4 | 1920 | 3.6 (1) | 520 (3) |
| 12 | 7.5 | 1125 (2) | 5.1 | 124 (4) |
| 13 | 6.1 | 1098 (2) | 5.8 | 928 (3) |
| 14 | 12.3 | 5166 | 7.3 | 3139 |
WBC indicates white blood cell; NCI, National Cancer Institute.
NCI grade for abnormal values only.